We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+16.62%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$952M
AUM Growth
+$137M
(+17%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
42.08%
Holding
736
New
57
Increased
199
Reduced
230
Closed
35
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold MiniShares Trust
GLDM
|
+$38.5M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$12.9M |
| 3 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$12.1M |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$6.7M |
| 5 |
ConocoPhillips
COP
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$24.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.09M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$7M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$5.34M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.1% |
| 2 | Technology | 7.29% |
| 3 | Healthcare | 5.27% |
| 4 | Financials | 3.93% |
| 5 | Industrials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.68B
| $324K | 0.03% |
6,531
-151
| -2% | -$7.4K |
2018 Q4
6 quarters
|
|
202
West Pharmaceutical
WST
$27B
| $321K | 0.03% |
1,415
-80
| -5% | -$15.7K |
2020 Q1
1 quarter
|
|
203
Idexx Laboratories
IDXX
$44.5B
| $312K | 0.03% |
945
-65
| -6% | -$18.8K |
2020 Q1
1 quarter
|
|
204
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$15.4B
| $311K | 0.03% |
24,750
| – | – |
2016 Q3
15 quarters
|
|
205
NVIDIA
NVDA
$5.25T
| $309K | 0.03% |
32,560
-5,680
| -15% | -$46K |
2015 Q2
20 quarters
|
|
206
Target
TGT
$70.9B
| $290K | 0.03% |
2,417
-480
| -17% | -$54.8K |
2017 Q2
12 quarters
|
|
207
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.9B
| $281K | 0.03% |
9,692
-880
| -8% | -$25.1K |
2018 Q4
6 quarters
|
|
208
Regeneron Pharmaceuticals
REGN
$81.8B
| $271K | 0.03% |
435
-55
| -11% | -$31.2K |
2019 Q4
2 quarters
|
|
209
Copart
CPRT
$25.7B
| $263K | 0.03% |
12,640
-880
| -7% | -$17.7K |
2020 Q1
1 quarter
|
|
210
Bristol-Myers Squibb
BMY
$124B
| $262K | 0.03% |
4,453
+483
| +12% | +$28.9K |
2015 Q4
18 quarters
|
|
211
Janus Henderson Short Duration Income ETF
VNLA
$3.56B
| $261K | 0.03% |
5,198
-314
| -6% | -$15.6K |
2018 Q2
8 quarters
|
|
212
Otis Worldwide
OTIS
$27.1B
| $256K | 0.03% |
+4,506
| New | +$233K |
2020 Q2
0 quarters
|
|
213
Kimberly-Clark
KMB
$35B
| $222K | 0.02% |
1,571
-122
| -7% | -$16.8K |
2013 Q4
26 quarters
|
|
214
Stryker
SYK
$113B
| $216K | 0.02% |
1,200
-68
| -5% | -$12.5K |
2014 Q1
25 quarters
|
|
215
ExxonMobil
XOM
$725B
| $216K | 0.02% |
4,826
-189
| -4% | -$8.48K |
2013 Q2
28 quarters
|
|
216
Carrier Global
CARR
$45.6B
| $213K | 0.02% |
+9,578
| New | +$178K |
2020 Q2
0 quarters
|
|
217
DuPont de Nemours
DD
$17.8B
| $213K | 0.02% |
3,196
+224
| +8% | +$13.1K |
2013 Q4
26 quarters
|
|
218
Exponent
EXPO
$3.42B
| $211K | 0.02% |
2,610
-105
| -4% | -$7.56K |
2019 Q4
2 quarters
|
|
219
iShares Select U.S. REIT ETF
ICF
$2.09B
| $208K | 0.02% |
4,128
-838
| -17% | -$41.3K |
2013 Q2
28 quarters
|
|
220
iShares Micro-Cap ETF
IWC
$1.27B
| $207K | 0.02% |
2,372
-4,665
| -66% | -$365K |
2013 Q4
26 quarters
|
|
221
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $202K | 0.02% |
3,700
-1,319
| -26% | -$71.1K |
2013 Q2
28 quarters
|
|
222
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $200K | 0.02% |
2,787
| – | – |
2016 Q4
14 quarters
|
|
223
Broadcom
AVGO
$1.6T
| $187K | 0.02% |
5,920
+40
| +0.7% | +$1.12K |
2014 Q4
22 quarters
|
|
224
Alibaba
BABA
$274B
| $184K | 0.02% |
852
-75
| -8% | -$15.6K |
2017 Q3
11 quarters
|
|
225
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $181K | 0.02% |
2,176
-59
| -3% | -$4.88K |
2017 Q2
12 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2020 Portfolio in Review
As of Q2 2020, Capital Analysts LLC held 736 positions worth $952M, up 17% from $815M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Capital Analysts LLC's Q2 2020 filing shows 57 new, 199 increased, 230 reduced and 35 closed positions. Its largest new stake was SPDR Gold MiniShares Trust: 1,126,647 shares worth $40M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $24.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 69% a quarter earlier, followed by Technology and Healthcare.
- Capital Analysts LLC's largest Q2 2020 buy was SPDR Gold MiniShares Trust: 1,126,647 shares worth $40M.
- Capital Analysts LLC added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2020, an estimated $12.9M increase.
- Capital Analysts LLC's biggest Q2 2020 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $24.1M.
- Capital Analysts LLC fully exited Raytheon Company in Q2 2020, selling an estimated $2.73M.
- Capital Analysts LLC's ten largest holdings make up 42% of its $952M portfolio in Q2 2020.
- Capital Analysts LLC opened 57 new positions and closed 35 in Q2 2020.
- Capital Analysts LLC's portfolio value rose 17% quarter-over-quarter to $952M.
Based on Capital Analysts LLC's 13F filing for Q2 2020, filed 7 Aug 2020.